Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.260
+0.040 (1.80%)
Oct 6, 2025, 4:00 PM EDT - Market closed
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $44.04 million as of October 6, 2025. Its market cap has decreased by -60.95% in one year.
Market Cap
44.04M
Enterprise Value
26.71M
1-Year Change
-60.95%
Ranking
Category
Stock Price
$2.26
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $44.04M, a decrease of -29.55%. That is a compound annual growth rate of -5.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 44.04M | -36.54% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | 51.96M | -16.87% |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |